AKBM.OL Stock — Price, Charts & Analysis

Aker BioMarine ASA (AKBM.OL) has no trailing P/E shown and a forward P/E of 28.83x. This places AKBM.OL in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

AKBM.OL trades with 28.83x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether AKBM.OL looks overvalued or undervalued.

AKBM.OL's P/E of 28.83x should be judged against Consumer Defensive peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

AKBM.OL's trailing EPS is -NOK 1.13 and forward EPS is NOK 4.23.

EPS, or earnings per share, shows how much profit Aker BioMarine ASA generated for each share. AKBM.OL's trailing EPS is -NOK 1.13, and investors usually prefer EPS that is positive and growing over time.

Aker BioMarine ASA has a market cap of NOK 10.70B, making AKBM.OL a large-cap stock based on the current market value shown on Worldtickers.

AKBM.OL's latest stock price on Worldtickers is NOK 122.00. The latest move is NOK 0.40 or 0.33%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

AKBM.OL's quote includes a latest price of NOK 122.00. The market open is NOK 121.60. Previous close is NOK 121.60. The intraday range is NOK 121.20 to NOK 122.60.

AKBM.OL is up in the latest quote, with a move of NOK 0.40 or 0.33%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

AKBM.OL generated NOK 227.20M in trailing revenue. Revenue growth is 4.70%, which helps show whether demand is expanding or slowing.

AKBM.OL's revenue growth is 4.70%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, AKBM.OL does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -NOK 10.00M.

Gross margin is 45.03%. Margins show how efficiently Aker BioMarine ASA turns revenue into profit.

Aker BioMarine ASA carries NOK 204.80M and holds NOK 19.70M in cash.

AKBM.OL holds NOK 19.70M on its balance sheet.

AKBM.OL's book value per share is NOK 15.44.

Institutions hold 5.67% of AKBM.OL shares. Insiders hold 89.32% of shares. Ownership mix helps investors understand how much of Aker BioMarine ASA is held by professional investors and company insiders.

AKBM.OL has 87.72M shares outstanding. Float shares are 8.71M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for AKBM.OL, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for AKBM.OL is NOK 4.23. Revenue growth is 4.70%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

AKBM.OL's trailing EPS is -NOK 1.13. Forward EPS is NOK 4.23. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

AKBM.OL is in the Consumer Defensive sector. Its earnings multiple is 28.83x. Its latest displayed growth metric is 4.70%. Compare these figures with sector peers before deciding whether Aker BioMarine ASA is stronger or weaker than average.

AKBM.OL trades at NOK 122.00. The stock trades at 28.83x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Aker BioMarine ASA's fundamentals.

AKBM.OL risks include company execution, valuation, competition in Consumer Defensive, interest rates, and broad market volatility. Beta is 0.31, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

AKBM.OL should be compared with companies in Packaged Foods. Its earnings multiple is 28.83x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Aker BioMarine ASA (AKBM.OL) operates in Consumer Defensive, specifically Packaged Foods. Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholip

AKBM.OL trades on Oslo. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

AKBM.OL stock is priced in NOK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Aker BioMarine ASA's official website listed on Worldtickers is www.akerbiomarine.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Aker BioMarine ASA employs about 258 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Aker BioMarine ASA is headquartered in Lysaker, Norway. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

AKBM.OL is in the Consumer Defensive sector and the Packaged Foods industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

AKBM.OL has traded between NOK 78.80 and NOK 124.00 over the past 52 weeks. At NOK 122.00, it is 1.61% below the high and 54.82% above the low. The 52-week range helps gauge long-term price momentum.

AKBM.OL is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is NOK 104.50 and its 200-day moving average is NOK 99.57.

AKBM.OL's RSI is 74.53. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a overbought momentum setup.

AKBM.OL's latest RSI reading is 74.53, which points to overbought momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for AKBM.OL is near NOK 103.20. Key resistance is near NOK 124.00. Breaks above resistance or below support can change the short-term technical setup.

AKBM.OL's nearest reported support level is NOK 103.20. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

AKBM.OL's nearest reported resistance level is NOK 124.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

AKBM.OL trades about 215.7K shares daily on average. The latest displayed volume is 5.16K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

AKBM.OL's MACD is 0.73, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

AKBM.OL is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 74.53 (overbought). MACD is bullish. Nearest support is around NOK 103.20. Resistance is around NOK 124.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is NOK 112.85 (7.75% from price). MA50 is NOK 104.50 (16.37% from price). MA200 is NOK 99.57 (22.12% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. AKBM.OL's MA20 is NOK 112.85. MA50 is NOK 104.50. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

AKBM.OL's pivot is near NOK 121.33. Support is near NOK 103.20. Resistance is near NOK 124.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for AKBM.OL is near NOK 115.00. These levels help define risk and possible follow-through zones after a breakout or breakdown.

AKBM.OL's Bollinger range is roughly NOK 99.80 to NOK 125.90. Band width is near 23.12%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

AKBM.OL's ATR-based typical daily range is about 2.90%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 5.16K shares. Average volume is about 215.7K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

AKBM.OL's all-time high shown on Worldtickers is NOK 129.08. Its all-time low is NOK 30.35. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

AKBM.OL has a beta of 0.31, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.